DRACHMAN JONATHAN G

Track

Insider profile

Performance

Overall performance
2.8
Performance over holding periods
2.8
30 days 90 days 120 days
Average return -8% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
DRACHMAN JONATHAN G's trades of Calithera Biosciences Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US Neurogene Inc (NGNE)
Transaction date
Purchase
Price
395.47
Quantity 3,858 +12.3%
Value US$4,780,736
US Neurogene Inc (NGNE)
Transaction date
Purchase
Price
341.89
Quantity 31,167 -35.9%
Value US$1,052,972
US Neurogene Inc (NGNE)
Transaction date
Purchase
Price
3.30
Quantity 136,436 +30.5%
Value US$449,898
US Neurogene Inc (NGNE)
Transaction date
Purchase
Price
3.08
Quantity 36,742 +8.9%
Value US$113,290
US Neurogene Inc (NGNE)
Transaction date
Purchase
Price
2.85
Quantity 76,822 +23.0%
Value US$218,559
US Seagen Inc (SGEN)
Transaction date
Planned sale
Price
53.12
Quantity 3,257 -1.9%
Value US$173,012
US Seagen Inc (SGEN)
Transaction date
Planned sale
Price
52.70
Quantity 7,200 -4.0%
Value US$379,440
US Seagen Inc (SGEN)
Transaction date
Planned sale
Price
47.89
Quantity 8,502 -6.0%
Value US$407,199
US Seagen Inc (SGEN)
Transaction date
Planned sale
Price
47.54
Quantity 10,000 -6.6%
Value US$475,414
US Seagen Inc (SGEN)
Transaction date
Planned sale
Price
54.54
Quantity 10,000 -8.0%
Value US$545,361
US Seagen Inc (SGEN)
Transaction date
Planned sale
Price
51.74
Quantity 3,418 -3.0%
Value US$176,847
US Seagen Inc (SGEN)
Transaction date
Planned sale
Price
56.75
Quantity 2,249 -1.9%
Value US$127,631
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2021-11-10 2021-11-10
B Purchase
35,515 -26.3%
419.93
US$1,088,225 		35,515 -26.3% 419.93 US$1,088,225
2021-06-07 2021-06-04
US Neurogene Inc (NGNE)
B Purchase
3,858 +12.3%
395.47
US$4,780,736 		3,858 +12.3% 395.47 US$4,780,736
2021-06-07 2021-06-03
US Neurogene Inc (NGNE)
B Purchase
31,167 -35.9%
341.89
US$1,052,972 		31,167 -35.9% 341.89 US$1,052,972
2019-09-11 2019-09-11
US Neurogene Inc (NGNE)
B Purchase
136,436 +30.5%
3.30
US$449,898 		136,436 +30.5% 3.30 US$449,898
2019-09-11 2019-09-10
US Neurogene Inc (NGNE)
B Purchase
36,742 +8.9%
3.08
US$113,290 		36,742 +8.9% 3.08 US$113,290
2019-09-11 2019-09-09
US Neurogene Inc (NGNE)
B Purchase
76,822 +23.0%
2.85
US$218,559 		76,822 +23.0% 2.85 US$218,559
2018-03-07 2018-03-05
US Seagen Inc (SGEN)
PlS Planned sale
3,257 -1.9%
53.12
US$173,012 		3,257 -1.9% 53.12 US$173,012
2018-03-07 2018-03-05
US Seagen Inc (SGEN)
PlS Planned sale
7,200 -4.0%
52.70
US$379,440 		7,200 -4.0% 52.70 US$379,440
2017-08-30 2017-08-28
US Seagen Inc (SGEN)
PlS Planned sale
8,502 -6.0%
47.89
US$407,199 		8,502 -6.0% 47.89 US$407,199
2017-08-25 2017-08-24
US Seagen Inc (SGEN)
PlS Planned sale
10,000 -6.6%
47.54
US$475,414 		10,000 -6.6% 47.54 US$475,414
2017-07-31 2017-07-27
US Seagen Inc (SGEN)
PlS Planned sale
10,000 -8.0%
54.54
US$545,361 		10,000 -8.0% 54.54 US$545,361
2016-11-03 2016-11-01
US Seagen Inc (SGEN)
PlS Planned sale
3,418 -3.0%
51.74
US$176,847 		3,418 -3.0% 51.74 US$176,847
2016-09-23 2016-09-22
US Seagen Inc (SGEN)
PlS Planned sale
2,249 -1.9%
56.75
US$127,631 		2,249 -1.9% 56.75 US$127,631